将来要改善肝细胞性肝癌化疗患者预后的措施应考虑同时给予减少病毒负荷量的抗病毒辅助治疗。
Future strategies to improve the prognosis of HCC patients undergoing chemotherapy should consider supportive therapy that incorporates antiviral therapies to reduce HBV viral load.
目的：观察榄香烯对小鼠肝细胞癌的治疗作用，为临床肝癌的治疗提供理论依据。
OBJECTIVE: To offer basic theory for clinical liver carcinoma treatment by observing the therapeutic effects of Elemene in loading tumor mice.
A 22鼠腹水肝癌细胞和鼠正常肝细胞膜脂的运动性。
A22 mouse ascites cell membrane lipids and those of the control cells.
目的：研究MDM2和突变型P 53蛋白表达与原发性肝细胞肝癌(HCC)发生的关系。
AIM: to study the expression of MDM2 and mutant-type P53 proteins in primary hepatocellular carcinoma (HCC).
化学诱导剂产生的肝癌模型与人肝癌有着相似性，所以这些数据对研究肝细胞癌的机制有重要意义。
As the HCC model has the similarity to human HCC, these data have important implications in understanding the mechanism of HCC.
肝细胞癌是最常见的肿瘤之一，而转移复发则成为提高肝癌病人预后的主要障碍。
Hepatocelluar carcinoma (HCC) is one of the most common human cancers worldwide, and metastatic recurrence is the major obstacle to improve the prognosis of HCC patients.
结果提示肝癌细胞膜上有癌周肝细胞膜不表达或表达甚微的抗原存在。
These findings suggest that there are different membranous antigen expressions between HCC and the surrounding liver cells.
肝细胞性肝癌是发病和死亡的常见原因。对于不能手术切除肿瘤的患者，予全身化疗是标准治疗方案之一。
HCC is a common cause of morbidity and mortality. For patients who are not candidates for curative surgery, systemic chemotherapy is one of the standard treatments.
现在，肝细胞肝癌在年轻人当中的发生率逐渐上升，你认为主要的原因是什么？
Now the incidence of hepatocellular carcinoma increased, prevalence increasingly on young people, do you think what is the main reason?
探讨慢性肝炎及肝细胞肝癌组织中CD 86表达与临床的关系。
To investigate the expression and clinical significance of CD86 in chronic hepatitis and hepatoma.
HBV感染是已知导致肝细胞癌(HCC)——一种最常见的肝癌类型的原因之一。
HBV infection is a known cause of hepatocellular carcinoma (HCC), the most common form of liver cancer.
持续病毒学应答可以降低肝硬化和肝病并发症的发生，降低肝癌(肝细胞性癌)和死亡的发生率。
Sustained virologic response can result in decreased cirrhosis and complications of liver disease, decreased rates of liver cancer (hepatocellular carcinoma), and decreased mortality.
肝细胞肝癌是世界上病死率最高的恶性肿瘤之一。
Hepatocellular carcinoma (HCC) is one of malignant tumor having the highest death rate worldwide.
目的通过检测肿瘤抑制基因产物pten蛋白在肝癌中的表达情况，探讨其作为一种评估肝细胞癌(HCC)生物学特征的分子标记的意义。
Objective to detect the expression of PTEN protein in hepatocellular carcinoma (HCC) to determine whether it can be used as a new molecular label for evaluation of biological characteristics of HCC.
最后有7.4%的患者发生为肝细胞肝癌。
Overall 7.4% of patients developed a hepatocellular carcinoma.
目的探讨MAGE-1基因编码的肿瘤相关抗原作为肝细胞性肝癌（HCC）主动免疫治疗攻击靶点的可能性。
Objective To explore the possibility of tumor associated antigen encoded by MAGE-1gene used as a tarest for immunotherapy in HCC patients.
开腹瘤块法复制兔VX2肝癌模型，其影像学表现类似人类原发性肝细胞肝癌，可进行进一步的临床实验研究。
The image manifestations of the VX2 liver tumor in rabbits are similar to those of hepatic primary carcinoma in human.
肝细胞癌(简称肝癌)是我国目前最常见的恶性肿瘤之一。
Hepatocellular carcinoma (HCC) is one of the most common malignant tumour in China.
目的观察白细胞介素2（IL-2）基因修饰的小鼠肝细胞经脾内移植后对肝脏免疫功能的影响以及对肝癌小鼠的治疗作用。
Objective To investigate the effects of intrasplenically transplanted , IL-2 gene-modified hepatocytes on the liver immune response and anti-tumor activity. Methods Murine fetal hepatocytes BNLCL.
目的：研究抑癌基因PTEN在人肝细胞肝癌中的表达及其与HCV核心蛋白间的关系。
Objective: To study the relationship between PTEN expression and HCV core protein in hepatocellular carcinoma (HCC).
目的：探讨人白细胞DR抗原(HLA- DR)在人原发性肝细胞癌(简称肝癌)的表达情况及其意义。
Objective: to require into the expression and significance of human leukocytic antigen DR (HLA - DR) in primary human hepatocellular carcinoma (HCC).
目的探讨超声衰减成像技术定量评估肝细胞性肝癌患者肝功能储备的价值。
Objective to investigate the value of quantitative assessment of hepatic fibrosis in predicting hepatic functional reserve of patients with hepatocellular carcinoma (HCC).
结论本研究所建立的裸鼠移植性人肝细胞肝癌模型成瘤率高，移植瘤生长良好，便于MRI观察，是一种适合于分子影像学研究的动物模型。
Conclusion The nude mouse model with FHCC, with ideal implantation and tumor growth rate, was convenient for MRI observation and suitable for molecular imaging research of human HCC.
FHIT基因的改变在肝细胞癌中是早期频发的事件，可以成为肝癌患者预后一种新的分子指标。
The alternation of FHIT gene is an early and frequent event of liver cancer, and FHIT gene as a new molecular indicator of liver cancer can monitor the prognosis of liver cancer patients.
目的：检测MCP-1在肝细胞性肝癌中表达的状况，分析其与肿瘤血管新生的关系。
Objective:To investigate the expression of monocyte chemoattractant protein-1(MCP-1) in hepatocellular carcinoma and the clinical significance.
结论：与动物致癌模型肝中存在卵圆细胞一样，人肝细胞肝癌肝中也存在同样形态和免疫表型特点的卵圆细胞。
Conclusion Oval cells that exhibit the same morphologic and immunophenotypic features as those seen during animal hepatocarcinogenesis are found in human HCC.
目的探讨原发性肝细胞癌（HCC）超声造影增强表现与肝癌细胞DNA增殖水平的关系及其临床意义。
Objective To investigate the relationship of hepatocellular carcinoma(HCC)between enhanced-ultrasonography characterization and DNA proliferation and its clinical value.
目的通过对肝细胞与肝癌细胞E钙粘素分布、表达和运动生长行为与其连结状态和骨架预张力状态相关关系的研究，探索肝癌细胞接触抑制丧失机制。
Object Through researching the distribution and expression of E-cadherin, cell movement and cytoskeleton in the liver cells and liver cancer cells, we explore the loss of contact inhibition mechanism.
结论：提示P16蛋白的表达与肝细胞性肝癌的分化程度有关，与肿瘤大小有关。
Conclusion: the expression of P16 protein is related to the degree of the differentiation but not related to the size of the humors.
肝细胞性肝癌是临床常见的一种恶性肿瘤，但目前对其发病机制仍不明确。
Hepatocellular carcinoma is one kind of clinical common malignant tumor, however, at present it was still not clear about its pathogenesis.
应用推荐